
Shridar Ganesan
Interim Deputy Director, Perlmutter Cancer Center · NYU Grossman School of Medicine
Credentials: · · · · ·
History
PresentPerlmutter Cancer Center · NYU Grossman School of Medicine
PresentCenter for Molecular Oncology · NYU Grossman School of Medicine

- 2000–2002
Medical Oncology
- 1999–2000
1989–1993
Research
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
Molecular Cell · 2001 · 1,014 citations
Genes & Development · 2005 · 1,010 citations
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer
Journal of Clinical Oncology · 2010 · 775 citations

24 papers
- KH
24 papers
- SA
20 papers

15 papers

11 papers

11 papers

11 papers

10 papers
Grants
- 1997–2029
National Cancer Institute · P30
Project lead · $946.7K · Rutgers Biomedical and Health Sciences
- 2021–2027
Mechanisms of the BRCA-Network in Tumorigenesis and Therapeutic Response
National Cancer Institute · P01
Project lead · $1.9M · Rutgers Biomedical and Health Sciences
- 2019–2025
National Cancer Institute · R01
Contact PI · $1.3M · Rutgers Biomedical and Health Sciences
- 2019–2024
Impact of Mutation Burden on Cancer Growth and the Immune Landscape
National Cancer Institute · R01
Contact PI · $2.6M · Rutgers Biomedical and Health Sciences
Clinical trials
- 2013–2030
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Principal investigator · Recruiting
Rutgers, The State University of New Jersey
- 2008
Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
Principal investigator · Withdrawn
Rutgers, The State University of New Jersey


